Covid-19 Info:
We keep delivering!
We have COVID-19 Safety Plan and are committed to keeping you safe.
Dosage Form | |
---|---|
Strength | 200 mg |
Generic Names | |
Manufacturer |
Favipiravir is approved for manufacture and sale in Japan as an influenza antiviral. It selectively inhibits the RNA polymerase of the influenza virus, an enzyme required for viral replication once human host cells are infected. COVID-19 also uses this enzyme to replicate and is classified into the same type of single-stranded RNA virus as influenza; hence, it is believed that Favipiravir may be effective in treating COVID-19. Favipiravir is only used when there is an outbreak of novel or re-emerging influenza virus infections in which other influenza antiviral drugs are either not effective or insufficiently effective. Its production and distribution is at the discretion of Japan?s Health, Labor and Welfare Ministry, so has never been distributed in the market and is not available at hospitals and pharmacies in Japan or overseas.
৳ 200.00
In stock
Dosage Form | |
---|---|
Strength | 200 mg |
Generic Names | |
Manufacturer |
Search from thousands of medicine and health products for your daily needs. Preskriptionpoint will ship them to your door with our fastest facility.
Accounts
Stop! This is a test environment, not a live site yet. please wait until the final publication for any order.
Something isn’t Clear?
Feel free to contact us, and we will be more than happy to answer all of your questions.
Covid-19:
We keep delivering!